Beijing Wandong Medical Technology Co Ltd
SSE:600055
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Beijing Wandong Medical Technology Co Ltd
Capital Expenditures
Beijing Wandong Medical Technology Co Ltd
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Beijing Wandong Medical Technology Co Ltd
SSE:600055
|
Capital Expenditures
-¥99m
|
CAGR 3-Years
-92%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
3%
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Capital Expenditures
-¥285.6m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Capital Expenditures
-¥166.9m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Capital Expenditures
-¥2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Capital Expenditures
-¥268.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-18%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Capital Expenditures
-¥1.9B
|
CAGR 3-Years
-78%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
Beijing Wandong Medical Technology Co Ltd
Glance View
Nestled in the bustling heart of Beijing's economic landscape, Beijing Wandong Medical Technology Co., Ltd. thrives as a beacon of innovation and resilience in the medical imaging sector. Founded with a vision to advance healthcare technology, Wandong has evolved into a formidable player in the design, manufacture, and distribution of cutting-edge medical imaging devices. The company's extensive product line spans from traditional X-ray systems to advanced MRI and CT systems, underscoring its commitment to covering a wide spectrum of imaging needs. By blending sophisticated technology with user-friendly interfaces, Wandong not only meets the diagnostic demands of hospitals and clinics but also enhances the efficiency and accuracy of medical professionals worldwide. Wandong's economic engine is powered primarily by its robust sales and service network, meticulously built over decades across China and beyond. This network enables the company to offer comprehensive after-sales services, fostering long-term customer relationships and ensuring a steady revenue stream. Furthermore, Wandong invests heavily in research and development, aligning with global technological advances and continuously upgrading its product offerings to meet international standards. By optimizing operations and penetrating acutely competitive markets, Beijing Wandong Medical Technology Co., Ltd. secures its position not just as a manufacturer but as a partner in healthcare progress, effectively translating technology into tangible health solutions that cater to an ever-growing global demand for quality medical care.
See Also
What is Beijing Wandong Medical Technology Co Ltd's Capital Expenditures?
Capital Expenditures
-99m
CNY
Based on the financial report for Dec 31, 2025, Beijing Wandong Medical Technology Co Ltd's Capital Expenditures amounts to -99m CNY.
What is Beijing Wandong Medical Technology Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
3%
Over the last year, the Capital Expenditures growth was -156%. The average annual Capital Expenditures growth rates for Beijing Wandong Medical Technology Co Ltd have been -92% over the past three years , -34% over the past five years , and 3% over the past ten years .